Response to 'A controversial consensus'; By the International Consensus Panel

Journal of Internal Medicine

Volumn 271, Issue 2, 2012, Pages 213-217

  Broderick, G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

BRAIN BIOPSY; BRAIN OXYGEN CONSUMPTION; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; CONSENSUS; DISEASE CLASSIFICATION; FLU LIKE SYNDROME; HOLTER MONITORING; HUMAN; IMMUNOREACTIVITY; INTERNATIONAL SYMPTOM SCALE; KINESIOTHERAPY; LETTER; LYMPHADENOPATHY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SORE THROAT;

CONSENSUS; FATIGUE SYNDROME, CHRONIC; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 84855915144     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02499.x     Document Type: Letter

References (56)

1. Van der Meer J, Lloyd A. A controversial consensus. J Intern Med 2011; Oct 11. DOI: 10.1111/j.1365-2796.2011.02468.x. [Epub ahead of print].
2. Carruthers BM, van de Sande MI, De Meirleir KL et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270:327-38.
3. Fluge Ø, Bruland O, Risa K et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLoS ONE 2011; 6:e26358.
4. Sharp MC, Archard LC, Banatvala JE et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118-21.
5. Reeves VC, Wagner D, Nisenbaum R et al. Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med 2005; 3: 19.
6. Jason LA, Najar N, Porter N, Reh C. Evaluating the Centers for Disease Control's empirical chronic fatigue syndrome case definition. J Disabil Pol Studies 2009; 20: 91-100.
7. Fukuda K, Straus SE, Hickie I et al. Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9.
8. Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003; 11: 7-116.
9. Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. Comparing the Fukuda et al. Criteria and the Canadian case definition for chronic fatigue syndrome. J Chronic Fatigue Syndr 2004; 12: 37-52.
10. Van Oosterwijck J, Nijs J, Meeus M et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome; an experimental study. J Intern Med 2010; 268: 265-78. [PMID: 20412374].
11. Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med 2010; 42: 884-90.
12. Yoshiuchi K, Farkas I, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006; 26: 83-6. [PMID: 16494597].
13. Goldstein JA. Chronic Fatigue Syndrome: The Limbic Hypothesis. Binghamptom, New York: Haworth Medical Press, 1993.
14. Neary PJ, Roberts AD, Leavins N, Harrison MF, Croll JC, Sexsmith JR. Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clin Physiol Funct Imaging 2008; 28: 364-72. [PMID: 18671793].
15. De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K. Exercise capacity in chronic fatigue syndrome. Arch Intern Med 2000; 170: 3270-13.
16. VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Post-exertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt) 2010; 18: 239-44.
17. Snell CF, VanNess JM, Stayer DF, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS). In Vivo 2005; 19: 387-90.
18. Jones DE, Hollingsworth KG, Jakovljevic DG et al. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest 2011; Jun 10. doi: [Epub ahead of print].
19. Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton JL. Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome. J Intern Med 2010; 267: 394-401. [PMID: 20433583].
20. Hollingsworth KG, Jones DE, Taylor R, Blamire AM, Newton JL. Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest 2010; 40: 608-15. [PMID: 20497461].
21. Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2001; 321: 163-7. [PMID: 11269790].
22. Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105: 15S-21S. [PMID: 9790477].
23. Miwa K, Fujita M. Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and "small heart". J Cardiol 2009; 54: 29-35. [PMID: 19632517].
24. Peckerman A, LaManca JJ, Qureishi B et al. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome. Psychosom Med 2003; 65: 889-95. [PMID: 14508037].
25. Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003; 326: 55-60. [PMID: 12920435].
26. Lerner AM, Lawrie C, Dworkin HS. Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome. Left ventricular dysfunction in a cohort. Chest 1993; 104: 1417-21. [PMID: 8222798].
27. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88: 767-73. [PMID: 8542261].
28. Mena I, Villanueva-Meyer J. Study of cerebral perfusion by NeuroSPECT in patients with chronic fatigue syndrome. In: Hyde BM, Goldstein J, Levine P, eds. The Clinical and Scientific Basis of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome. Ottawa, Ontario & Ogdensburg, NY: The Nightingale Research Foundation, 1992; 432-8.
29. Goldberg MJ, Mena I, Darcourt J. NeuroSPECT findings in children with chronic fatigue syndrome. J Chronic Fatigue Syndr 1997; 3: 61-6.
30. Ichise M, Salit I, Abbey S et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1995; 13: 767-72.
31. Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci 2001; 301: 9-11. [PMID: 21167506].
32. Schutzer SE, Angel TE, Liu T et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE 2011; 6: e17287.
33. Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med 1998; 105: 50S-3S. [PMID: 9790482].
34. de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage 2005; 26: 777-81.
35. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 2004; 4: 14. [PMID: 15461817].
36. Mathew SJ, Mao X, Keegan KA et al. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (q)H MRS imaging study. NMR Biomed 2009; 22: 251-8.
37. Meeus M, Nijs J, Huybrechts S, Truijen S. Evidence for generalized hyperalgesia in chronic fatigue syndrome: case control study. Clin Rheumatol 2010; 29: 393-8.
38. Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue GH. Altered central nervous system signal during motor performance in chronic fatigue syndrome. Clin Neurophysiol 2004; 115: 2372-81. [PMID: 15351380].
39. Lange G, Steffner J, Cook DB et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. NeuroImage 2005; 26: 513-4. [PMID: 15907308].
40. Flor-Henry P, Lind JC, Koles ZJ. EEG source analysis of chronic fatigue syndrome. Psychiatry Res 2010; 181: 155-65.
41. Cook DB, O'Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among fatigue syndrome patients and controls. NeuroImage 2007; 36: 108-22.
42. Tirelli U, Chierichetti F, Tavio M et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S-8S.
43. Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci 2001; 107: 1-6.
44. Chen R, Liang FX, Moriya J et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res 2008; 36: 867-74.
45. Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010; 24: 1209-17.
46. Lorusso L, Mikhaylova SW, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009; 8: 287-91.
47. Fletcher MA, Zeng XR, Maher K et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV. PLoS ONE 2010; 5: e10817.
48. Mihaylova I, DeRuyter M, Rummens JL, Basmans E, Maes M. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett 2007; 28: 477-83.
49. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403-10.
50. Cameron B, Hirschberg DL, Rosenberg-Hassan Y, Ablashi D, Lloyd AR. Serum cytokine levels in postinfective fatigue syndrome. Clin Infect Dis 2010; 50: 278-9.
51. Carlo-Stella N, Badulli C, De Sivestri A et al. The first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006; 24: 179-82.
52. De Meirleir K, Bisbal C, Campine I et al. A 37kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99-105.
53. Sudolnik RJ, Lombardia V, Peterson DL et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17: 377-85.
54. Nijs J, Frémont M. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications. Expert Opin Ther Targets 2008; 12: 281-9.
55. Nijs J, De Meirleir K, Meeus M, McGregor NR, Englebienne P. Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response. Med Hypotheses 2004; 62: 759-65.
56. White AT, Light AR, Hughen RW et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 2010; 47: 615-24.